DocGo (NASDAQ:DCGO) Reaches New 1-Year High – What’s Next?

DocGo Inc. (NASDAQ:DCGO)’s stock price reached a new 52-week high on Monday . The company traded as high as $5.33 and last traded at $5.15, with a volume of 119313 shares traded. The stock had previously closed at $5.04.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reissued a “buy” rating and set a $7.00 price target on shares of DocGo in a research note on Thursday, January 16th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $6.10.

DocGo Stock Performance

The firm has a market capitalization of $527.09 million, a P/E ratio of 18.38, a price-to-earnings-growth ratio of 13.82 and a beta of 1.00. The firm has a 50-day moving average of $4.39 and a 200-day moving average of $3.87.

DocGo (NASDAQ:DCGO) last posted its earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. DocGo had a net margin of 4.35% and a return on equity of 8.90%. The company had revenue of $138.68 million during the quarter, compared to analyst estimates of $139.59 million. During the same period in the prior year, the business posted $0.05 earnings per share. Equities analysts anticipate that DocGo Inc. will post 0.25 EPS for the current fiscal year.

Insider Buying and Selling

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the company’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the transaction, the general counsel now owns 175,645 shares in the company, valued at approximately $779,863.80. This represents a 11.62 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Centiva Capital LP bought a new stake in DocGo in the 3rd quarter worth about $43,000. Intech Investment Management LLC bought a new position in DocGo during the third quarter valued at approximately $62,000. SG Americas Securities LLC boosted its holdings in DocGo by 97.5% in the third quarter. SG Americas Securities LLC now owns 38,147 shares of the company’s stock worth $127,000 after purchasing an additional 18,835 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in DocGo by 31.6% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock worth $125,000 after purchasing an additional 9,696 shares during the period. Finally, Victory Capital Management Inc. raised its stake in DocGo by 100.3% during the 3rd quarter. Victory Capital Management Inc. now owns 51,349 shares of the company’s stock valued at $170,000 after buying an additional 25,714 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.